tenofovir alafenamide

4 Key FDA Decisions Expected in November and December
24/7 Wall St
Sun, 11/1/15 - 11:18 am
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide